Cargando…

One year of SARS-CoV-2 evolution

Since the outbreak of SARS-CoV-2, the etiologic agent of the COVID-19 pandemic, the viral genome has acquired numerous mutations with the potential to increase transmission. One year after its emergence, we now further analyze emergent SARS-CoV-2 genome sequences in an effort to understand the evolu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Aiping, Wang, Lulan, Zhou, Hang-Yu, Ji, Cheng-Yang, Xia, Shang Zhou, Cao, Yang, Meng, Jing, Ding, Xiao, Gold, Sarah, Jiang, Taijiao, Cheng, Genhong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Published by Elsevier Inc. 2021
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7903908/ https://www.ncbi.nlm.nih.gov/pubmed/33676588 http://dx.doi.org/10.1016/j.chom.2021.02.017

Ejemplares similares

Convergent evolution of SARS-CoV-2 in human and animals
por: Zhou, Hang-Yu, et al.
Publicado: (2021)

Genomic annotation and molecular evolution of monkeypox virus outbreak in 2022
por: Wang, Lulan, et al.
Publicado: (2022)

The battle between host and SARS-CoV-2: Innate immunity and viral evasion strategies
por: Zhang, Shilei, et al.
Publicado: (2022)

Genome Composition and Divergence of the Novel Coronavirus (2019-nCoV) Originating in China
por: Wu, Aiping, et al.
Publicado: (2020)

Detecting Potentially Adaptive Mutations from the Parallel and Fixed Patterns in SARS-CoV-2 Evolution
por: Ji, Cheng-Yang, et al.
Publicado: (2022)

SARS-CoV-2 virus NSP14 Impairs NRF2/HMOX1 activation by targeting Sirtuin 1
por: Zhang, Shilei, et al.
Publicado: (2022)

The Evolutionary Dance between Innate Host Antiviral Pathways and SARS-CoV-2
por: Aliyari, Saba R., et al.
Publicado: (2022)

Integrating computational modeling and functional assays to decipher the structure-function relationship of influenza virus PB1 protein
por: Li, Chunfeng, et al.
Publicado: (2014)

Conserved Pattern and Potential Role of Recurrent Deletions in SARS-CoV-2 Evolution
por: Weng, Shenghui, et al.
Publicado: (2022)

Why is the SARS-CoV-2 Omicron variant milder?
por: Xia, Bingqing, et al.
Publicado: (2022)

The Role of Antibody Testing for SARS-CoV-2: Is There One?
por: Theel, Elitza S., et al.
Publicado: (2020)

Early Introduction and Community Transmission of SARS-CoV-2 Omicron Variant, New York, New York, USA
por: Liu, Dakai, et al.
Publicado: (2023)

Mapping Genetic Events of SARS-CoV-2 Variants
por: Qin, Luyao, et al.
Publicado: (2022)

Genetic differentiation and diversity of SARS-CoV-2 Omicron variant in its early outbreak
por: Weng, Shenghui, et al.
Publicado: (2022)

Regulation of Early Host Immune Responses Shapes the Pathogenicity of Avian Influenza A Virus
por: Sun, Jiya, et al.
Publicado: (2019)

SARS-CoV-2 Evolution: On the Sudden Appearance of the Omicron Variant
por: Berkhout, Ben, et al.
Publicado: (2022)

Web Resources for SARS-CoV-2 Genomic Database, Annotation, Analysis and Variant Tracking
por: Cheng, Yexiao, et al.
Publicado: (2023)

Origin and Reversion of Omicron Core Mutations in the Evolution of SARS-CoV-2 Genomes
por: Zhao, Xinwei, et al.
Publicado: (2022)

Evolution of Telehealth in Ambulatory Psychiatry: A One Year Perspective
por: Peck, Pamela, et al.
Publicado: (2021)

Evaluation of vaccine effectiveness against SARS‐CoV‐2 variants by serological epitope profiling
por: Li, Cheng, et al.
Publicado: (2023)

25-Hydroxycholesterol is a potent SARS-CoV-2 inhibitor
por: Zu, Shulong, et al.
Publicado: (2020)

covSampler: A subsampling method with balanced genetic diversity for large-scale SARS-CoV-2 genome data sets
por: Cheng, Yexiao, et al.
Publicado: (2022)

Integrated interactome and transcriptome analysis reveals key host factors critical for SARS-CoV-2 infection
por: Sheng, Jie, et al.
Publicado: (2023)

Combined treatment of molnupiravir and favipiravir against SARS-CoV-2 infection: One + zero equals two?
por: Eloy, Philippine, et al.
Publicado: (2021)

Genomic evidence for divergent co-infections of co-circulating SARS-CoV-2 lineages
por: Zhou, Hang-Yu, et al.
Publicado: (2022)

SARS genome patent: symptom or disease?
por: Gold, E Richard
Publicado: (2003)

Evolution of SARS-CoV-2: BA.4/BA.5 Variants Continues to Pose New Challenges
por: Quadir, Neha, et al.
Publicado: (2022)

SARS-CoV-2 vaccination for immune-comprised patients: More is required
por: Li, Hui, et al.
Publicado: (2021)

Comparative Transcriptome Analysis Reveals the Intensive Early Stage Responses of Host Cells to SARS-CoV-2 Infection
por: Sun, Jiya, et al.
Publicado: (2020)

Precautions after vaccinating immunosuppressed patients with mRNA-based vaccines against SARS-CoV-2: does one size fit all?
por: Tau, Noam, et al.
Publicado: (2021)

Rapid and accurate identification of SARS-CoV-2 variants containing E484 mutation
por: Zhang, Yuan, et al.
Publicado: (2021)

Pathogenicity of SARS‐CoV‐2 Omicron
por: Chu, Hin, et al.
Publicado: (2022)

Antigenic imprinting in SARS‐CoV‐2
por: Reincke, S. Momsen, et al.
Publicado: (2022)

Modeling influenza sequence evolution for vaccination
por: Jiang, Taijiao
Publicado: (2012)

Has the door closed on hydroxychloroquine for SARS-COV-2?
por: Paul, Mical
Publicado: (2021)

SARS‐CoV‐2: March toward adaptation
por: Benedetti, Francesca, et al.
Publicado: (2020)

Could Sars-Cov2 affect MS progression?
por: Di Stadio, Arianna, et al.
Publicado: (2020)

Sports Health During the SARS-Cov-2 Pandemic
por: Timpka, Toomas
Publicado: (2020)

The pathogenesis and alternative treatment of SARS-CoV2
por: Choi, Jun-Yong, et al.
Publicado: (2020)

The prospects for the SARS‐CoV‐2 pandemic in Africa
por: Quaresima, Virginia, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_qq76a4l4ro4ompgohcjaab5hdr